Fig. 8
From: Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
Analysis of DNA fragmentation in human CRC cell lines treated with single and combined treatments of Sora, Cur, Que or Kmf. A and B SW1116 and SW837 CRC cell lines treated with Sora (5 µM), Cur (200 and 400 µM) and their simultaneous or sequential treatments. C SW1116 treated with Sora (5 µM), Que (200 and 400 µM) and their simultaneous treatments. D SW837 treated with Sora (5 µM), Kmf (200 and 400 µM), and their sequential treatments for 72 h. M, 1,000 bp DNA marker; Sora, sorafenib; Cur, curcumin; Que, quercetin; Kmf, kaempherol; UT, untreated; CRC, colorectal cancer